This study explores endogenous angiogenesis inhibitors, including plasminogen activator and matrix metalloprotease inhibitors, as potential anti-angiogenesis targets. These factors are crucial for controlling new blood vessel growth in malignant tumors.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: